RXMD has enjoyed YOY revenue increases for the last couple of years by making two acquisitions. Revenue growth, however, the revenue growth rate is shrinking lately. RXMD will be hammered down at this rate. If all the financial numbers are lies as some people suggests, they could give us better numbers. I believe RXMD is not lying to us. Armen is trying to expand their business model and trying to profitable by doing so. He is trying to grow by adopting a SaaS full subscription model. IMO. It is a highly scalable model. The subscription number could potentially increase rapidly. $10 mills is not big money if RXMD has a lot of cash. Unfortunately, they don't and they are not even SEQ reporting. My question is the timing of the LOI. Was it that urgent? He could have done it after S-1. Many people don't seem to like it. The price is going in the wrong direction. If it goes up, less shares need to be issued. I am hoping for that. We don't want issue so many shares for sure. I am not a good trader. I am not trying to pump this. I just want RXMD to be successful.